Thursday, April 18, 2019
    Latest

    Pharma Watch

    Home Pharma Watch
    Psychiatric
    Pharma Watch

    Adverse Event: GSK’s Belimumab Increased Risk of Serious Psychiatric Events Seen...

    0
    Pharma Watch

    Novo Nordisk and Gilead Team up on NASH Trial

    0
    China Pharma
    Pharma Watch

    PharmaWatch: Novartis Receives Approval for Psoriasis Drug Cosentyx in China

    0
    Parkinsons
    Pharma Watch

    Is it Time to Yank Parkinson’s Drug Nuplazid Off the Market?

    0
    Pharma Watch

    $100 Million Investment to Kalundborg—the World’s Largest Insulin Production Center

    0
    Pharma Watch

    Boehringer Ingelheim Acquires Novel Oncology Delivery Technology

    0
    Pharma Watch

    Pfizer Invests $51 Million to Access Gene Therapy Platform for Liver...

    0
    Pharma Watch

    AstraZeneca Stock Down on Announcement

    0
    Pharma Watch

    Xbiotech, Maker of HS Drug Candidate Stock Up

    0
    Pharma Watch

    Mackie Research Analysts Suggests Sell of Promis Neurosciences

    0
    1234Page 1 of 4
    - Advertisement -

    EDITOR PICKS

    TrialSite News is the only digital media dedicated 100% to transparent and open coverage of clinical research trial sites around the globe. Based in the Silicon Slopes in downtown Salt Lake City, Utah, we are founded by a team of experts in the clinical trials industry and dedicated to transparency, quality and clinical trial innovation.

    307 West 200 South #5002
    Salt Lake City, UT 84101

    Contact us: admin@trialsitenews.com
    © TrialSite News, Inc. All Rights Reserved